Novel monitoring tools tackle chemical surface waters pollution
New report prepared in the context of the EU water framework directive
2015-03-13
(Press-News.org) With the socio-economic developments of the last decades, new emerging compounds have been produced, released and discharged through different point and diffuse sources in European rivers, lakes, and marine-coastal and transitional waters. Treated municipal wastewaters contain a multitude of organic chemicals including pharmaceuticals, hormones, and personal care products, which are continuously introduced into aquatic ecosystems. Their possible effects on the environment and human health is often unknown. The exposure of organisms, communities and humans to mixtures of chemical compounds must be considered to be the most common exposure scenario, but for technical and economical reasons, it is not possible to detect and quantify all chemical substances that are present in the aquatic environment.
To tackle the challenge of current and future chemical pollution, new monitoring and diagnostic tools are needed that can integrate and support the chemical monitoring programmes of surface waters. The Water Framework Directive (WFD) is the main legislation for the protection of water resources and sets the goal of achieving a "good status" for all Europe's surface waters and groundwaters by 2015 with the aim to protect environment and human health. The control of the chemical pollution is based on the compliance with legally binding Environmental Quality Standards for selected chemical pollutants (priority substances) of EU-wide concern and for the specific pollutants selected at national or river-basin level.
In the context of the expert group CMEP (chemical monitoring and emerging pollutants) of the CIS (Common Implementation Strategy) of the WFD, a European technical report on aquatic effect-based monitoring tools has been published with the specific aim of supporting the monitoring programmes (surveillance, operational and investigative) of the WFD. The activity was chaired by Sweden and Italy and progressively involved several Member States and stakeholders in an EU-wide drafting group of 47 experts that includes also the JRC (Joint Research Centre) of the European Commission. The Technical Report has been approved by the Strategic Coordination Group of the WFD and endorsed by the European Water Directors in December 2013.
The present paper "The European technical report on aquatic effect-based monitoring tools under the water framework directive" published in Springer's journal Environmental Sciences Europe, summarizes the major technical contents and findings of the report with the aim to strengthen the link between science and regulation.
The tools described in the report include bioassays in vitro that can assess for example estrogenicity caused by pharmaceuticals, in vivo assays able to detect for example neurotoxicity and embryotoxicity effects, biomarkers for the detection of mutagenic effects, ecological indicators such as Spear, and innovative methods as the use of OMICs. Furthermore, methodologies such as EDA (effect directed analysis), which are useful to identify unknown pollutants, are also suggested.
In the context of the EU legislation, these tools can be used for example as screening tools, to establish early warning systems for human health protection, to detect the effects of chemical mixtures or chemicals that are not routinely analysed, to support investigative monitoring where causes of a decline of specific species are unknown, and to provide additional support in sediment quality assessment. Several case studies are included in the annex of the report as well as specific fact-sheets for several single specific bioassays and biomarkers. The monitoring tools included in the report should support and complement the surface waters chemical monitoring programmes foreseen by the recent Directive 2013/39/EU on the priority substances. They should be spread in the Member States through training courses and field pilot studies with the final aim of improving the protection of environment and human health.
INFORMATION:
Reference: Wernersson, A.-S., Carere, M. et al. The European technical report on aquatic effect-based monitoring tools under the water framework directive. Environmental Sciences Europe (2015, 27:7) DOI 10.1186/s12302-015-0039-4. The report is part of Springer's open access publishing portfolio SpringerOpen and is freely available online.
ELSE PRESS RELEASES FROM THIS DATE:
2015-03-13
Although listening to music is common in all societies, the biological determinants of listening to music are largely unknown. According to a latest study, listening to classical music enhanced the activity of genes involved in dopamine secretion and transport, synaptic neurotransmission, learning and memory, and down-regulated the genes mediating neurodegeneration. Several of the up-regulated genes were known to be responsible for song learning and singing in songbirds, suggesting a common evolutionary background of sound perception across species.
Listening to music ...
2015-03-13
Atomic force microscopy (AFM) is a leading tool for imaging, measuring, and manipulating materials with atomic resolution - on the order of fractions of a nanometer.
AFM images surface topography of a structure by "touching" and "feeling" its surface by scanning an extremely fine needle (the diameter of the tip is about 5 nanometers, about 1/100 of light wavelength or 1/10,000 of a hair) on the surface.
This technique has been applied to image solid materials with nanometer resolution, but it has been difficult to apply AFM for a soft and large sample like eukaryotic ...
2015-03-13
Metastatic melanoma is the leading cause of skin cancer deaths in the United States; once melanoma has spread (metastasized), life expectancy for patients can be dramatically shortened. At present, the reference therapy for patients diagnosed with metastatic melanoma is Dacarbazine (DTIC), which is associated with poor patient outcomes.
In a study published in Molecular Cancer Research, March 12, 2015, the laboratory of Mary J.C. Hendrix, PhD, in collaboration with other scientists found that standard treatments for metastatic melanoma are not effective against a growth ...
2015-03-13
An FDA-approved drug for high blood pressure, guanabenz, prevents myelin loss and alleviates clinical symptoms of multiple sclerosis (MS) in animal models, according to a new study. The drug appears to enhance an innate cellular mechanism that protects myelin-producing cells against inflammatory stress. These findings point to promising avenues for the development of new therapeutics against MS, report scientists from the University of Chicago in Nature Communications on Mar. 13.
"Guanabenz appears to enhance the cell's own protective machinery to diminish the loss of ...
2015-03-13
Almost all patients with a group of blood cancers called B-cell malignancies have two prominent "fingerprints" on the surface of leukemia and lymphoma cancers, called CD22 and CD19, Vallera explained. To develop the drug, Vallera and colleagues chose two antibody fragments that each selectively bind to CD19 and CD22. They used genetic engineering to attach these two antibodies to a potent toxin, the bacterial diphtheria toxin. When the antibody fragments bind to the two targets on the cancer cell, the entire drug enters the cell, and the toxin kills the cell.
Vallera; ...
2015-03-13
Boston, Mass., USA - Today at the 93rd General Session and Exhibition of the International Association for Dental Research, researcher Bertha A. Chavez Gonzalez, Universidade de Minas Gerias, Lima, San Borja, Peru, will present a study titled "Birth Weight and Pregnancy Complications Associated With the Enamel Defects." The IADR General Session is being held in conjunction with the 44th Annual Meeting of the American Association for Dental Research and the 39th Annual Meeting of the Canadian Association for Dental Research.
This cross-sectional representative study ...
2015-03-13
Boston, Mass., USA - Today at the 93rd General Session and Exhibition of the International Association for Dental Research, researcher Aderonke A. Akinkugbe, University of North Carolina at Chapel Hill, USA, will present a study titled "Environmental Tobacco Smoke is Associated With Periodontitis in U.S. Non-smokers." The IADR General Session is being held in conjunction with the 44th Annual Meeting of the American Association for Dental Research and the 39th Annual Meeting of the Canadian Association for Dental Research.
Periodontitis affects approximately 47% of ...
2015-03-13
Leading public health researchers today [Friday 13 March 2015] call for the sale of tobacco to be phased out by 2040, showing that with sufficient political support and stronger evidence-based action against the tobacco industry, a tobacco-free world - where less than 5% of adults use tobacco - could be possible in less than three decades.
Writing in a major new Series in The Lancet, an international group of health and policy experts, led by Professors Robert Beaglehole and Ruth Bonita from the University of Auckland in New Zealand, call on the United Nations (UN) to ...
2015-03-13
Estoril, Portugal: Treating respiratory disease is often difficult because drugs have to cross biological barriers such as respiratory tissue and mucosa, and must therefore be given in large quantities in order for an effective amount to reach the target. Now researchers from Germany, Brazil and France have shown that the use of nanoparticles to carry antibiotics across biological barriers can be effective in treating lung infections. Doing so allows better delivery of the drug to the site of infection, and hence prevents the development of antibiotic resistance which ...
2015-03-12
Highlights
Among pregnant women, the risk for adverse pregnancy outcomes--such as preterm delivery or the need for neonatal intensive care--increased across stages of chronic kidney disease.
The risks of intrauterine death or fetal malformations were not higher in women with chronic kidney disease.
An estimated 26 million people in the United States have chronic kidney disease.
Washington, DC (March 12, 2015) -- Even mild kidney disease during pregnancy may increase certain risks in the mother and baby, according to a study appearing in an upcoming issue of ...
LAST 30 PRESS RELEASES:
[Press-News.org] Novel monitoring tools tackle chemical surface waters pollution
New report prepared in the context of the EU water framework directive